Molecular formula: | C19H16F2N3NaO5 |
Average mass: | 427.339 |
Monoisotopic mass: | 427.095571 |
ChemSpider ID: | 32702138 |
2 of 2 defined stereocentres
(3S,11aR)-8-[(2,4-Difluorobenzyl)carbamoyl]-3-méthyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate de sodium
[French]
[ACD/IUPAC Name]1051375-13-3
[RN]3L12PT535M
[UNII]CABOTEGRAVIR SODIUM
[USAN]GSK1265744B
Natrium-(3S,11aR)-8-[(2,4-difluorbenzyl)carbamoyl]-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olat
[German]
[ACD/IUPAC Name]Oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-, sodium salt, (3S,11aR)- (1:1)
[ACD/Index Name]S-265744B
Sodium (3S,11aR)-8-[(2,4-difluorobenzyl)carbamoyl]-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate
[ACD/IUPAC Name]GSK 1265744B
GSK-1265744B
MFCD25976749
[MDL number]S 265744B
Sodium (3S,11aR)-8-((2,4-difluorobenzyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate
Vocabria